Entering text into the input field will update the search result below

Takeda Pharmaceutical Non-GAAP EPS of ¥456.00, revenue of ¥3071.3B; reaffirms full-year guidance

  • Takeda Pharmaceutical press release (NYSE:TAK): 9M Non-GAAP EPS of ¥456.00.
  • Revenue of ¥3071.3B (+19.8% Y/Y).
  • FY Guidance: Revenue guidance unchanged to ¥3.93T. Core EPS of ¥525; Core Operating Profit of ¥1,180.0B and Free Cash Flow of ¥650.0B - ¥750.0B.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.